KRISTEN VILLAR: Open Payments
NPI 1790442507 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,989 in 214 payments from 25 companies in 2025. Trend: 2023 $4,413 · 2024 $5,971 · 2025 $3,989
Food & beverage: $3,608Consulting: $325Education: $56
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $609 |
| Neurocrine BioSciences, Inc. | 49 | $524 |
| Biogen, Inc. | 10 | $354 |
| TG Therapeutics, Inc. | 9 | $338 |
| EMD Serono, Inc. | 6 | $255 |
| PFIZER INC. | 26 | $250 |
| Alexion Pharmaceuticals, Inc. | 1 | $175 |
| Lundbeck LLC | 6 | $151 |
| GENZYME CORPORATION | 5 | $149 |
| Amgen Inc. | 8 | $145 |
Products named: INGREZZA, BRIUMVI, QULIPTA, TYSABRI, NURTEC ODT, ULTOMIRIS, UBRELVY, REXULTI.
Industry payments across LA — which companies pay providers there.
